Serum response factor

From WikiMD's WELLNESSPEDIA

Serum response factor (SRF) is a transcription factor that binds to the serum response element (SRE), a short sequence of DNA found in the promoter region of some genes. It is a crucial component of the cellular machinery that regulates gene expression. SRF is involved in a wide range of physiological processes, including cell growth and differentiation, muscle development, and the response to serum stimulation.

Structure[edit]

SRF is a member of the MADS (MCM1, Agamous, Deficiens, and SRF) box superfamily of transcription factors. It contains a highly conserved DNA-binding domain, known as the MADS box, which allows it to bind to the SRE in the promoter region of target genes. The MADS box is approximately 58 amino acids in length and is located towards the N-terminus of the protein.

Function[edit]

SRF regulates the expression of a large number of genes that are involved in a variety of cellular processes. These include genes that encode proteins involved in cell cycle regulation, cytoskeletal organization, and muscle differentiation. SRF can either activate or repress the transcription of these genes, depending on the context.

In response to serum stimulation, SRF binds to the SRE in the promoter region of immediate early genes, such as c-fos, and activates their transcription. This is a crucial step in the cellular response to growth signals.

In muscle cells, SRF plays a key role in the regulation of muscle-specific genes. It binds to the SRE in the promoter region of these genes and activates their transcription, leading to muscle differentiation.

Clinical significance[edit]

Alterations in SRF function have been implicated in a number of diseases, including cancer, cardiovascular disease, and neurodegenerative disease. In cancer, overexpression of SRF has been observed in several types of tumors, and it has been suggested that SRF may contribute to tumor growth and progression. In cardiovascular disease, mutations in SRF have been linked to congenital heart defects and cardiomyopathy. In neurodegenerative disease, changes in SRF activity have been associated with Alzheimer's disease and Parkinson's disease.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.